| Dr Michael S Maehara, MD | |
|
2220 Clark Ave, Long Beach, CA 90815-2521 | |
| (562) 597-4181 | |
| (562) 597-7083 |
| Full Name | Dr Michael S Maehara |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 43 Years |
| Location | 2220 Clark Ave, Long Beach, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316969629 | NPI | - | NPPES |
| 00A398150 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | A39815 (California) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 39815 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pih Hospital - Downey | Downey, CA | Hospital |
| Los Alamitos Medical Center | Los alamitos, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pih Health Physicians | 8426951328 | 439 |
News Archive
Sun Knowledge, Ltd., a leading Healthcare Insurance provider of Knowledge Process Outsourcing (KPO) services, will attend the Pharmacy Benefit Management Institute's Annual Drug Benefit Conference in Phoenix, Az., from February 17-19.
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis, according to a study in the October 3 issue of JAMA.
Individuals with Alzheimer's disease who are hospitalized are at risk for adverse outcomes including institutionalization, cognitive decline, and death, show study results.
The U.S. Food and Drug Administration today exercised its new authority under the Food and Drug Administration Amendments Act of 2007 (FDAAA) to require manufacturers of "conventional" antipsychotic drugs to make safety-related changes to prescribing information, or labeling, to warn about an increased risk of death associated with the off-label use of these drugs to treat behavioral problems in older people with dementia.
› Verified 8 days ago
| Entity Name | Pih Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609233899 PECOS PAC ID: 8426951328 Enrollment ID: O20040128001177 |
News Archive
Sun Knowledge, Ltd., a leading Healthcare Insurance provider of Knowledge Process Outsourcing (KPO) services, will attend the Pharmacy Benefit Management Institute's Annual Drug Benefit Conference in Phoenix, Az., from February 17-19.
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis, according to a study in the October 3 issue of JAMA.
Individuals with Alzheimer's disease who are hospitalized are at risk for adverse outcomes including institutionalization, cognitive decline, and death, show study results.
The U.S. Food and Drug Administration today exercised its new authority under the Food and Drug Administration Amendments Act of 2007 (FDAAA) to require manufacturers of "conventional" antipsychotic drugs to make safety-related changes to prescribing information, or labeling, to warn about an increased risk of death associated with the off-label use of these drugs to treat behavioral problems in older people with dementia.
› Verified 8 days ago
| Entity Name | Pioneer Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548303589 PECOS PAC ID: 1759317696 Enrollment ID: O20050712001246 |
News Archive
Sun Knowledge, Ltd., a leading Healthcare Insurance provider of Knowledge Process Outsourcing (KPO) services, will attend the Pharmacy Benefit Management Institute's Annual Drug Benefit Conference in Phoenix, Az., from February 17-19.
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis, according to a study in the October 3 issue of JAMA.
Individuals with Alzheimer's disease who are hospitalized are at risk for adverse outcomes including institutionalization, cognitive decline, and death, show study results.
The U.S. Food and Drug Administration today exercised its new authority under the Food and Drug Administration Amendments Act of 2007 (FDAAA) to require manufacturers of "conventional" antipsychotic drugs to make safety-related changes to prescribing information, or labeling, to warn about an increased risk of death associated with the off-label use of these drugs to treat behavioral problems in older people with dementia.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael S Maehara, MD 75 Remittance Dr Dept 6008, Chicago, IL 60675-6008 Ph: (562) 282-1419 | Dr Michael S Maehara, MD 2220 Clark Ave, Long Beach, CA 90815-2521 Ph: (562) 597-4181 |
News Archive
Sun Knowledge, Ltd., a leading Healthcare Insurance provider of Knowledge Process Outsourcing (KPO) services, will attend the Pharmacy Benefit Management Institute's Annual Drug Benefit Conference in Phoenix, Az., from February 17-19.
WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). As a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech's facility meets the highest standards of animal care and research practices.
A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis, according to a study in the October 3 issue of JAMA.
Individuals with Alzheimer's disease who are hospitalized are at risk for adverse outcomes including institutionalization, cognitive decline, and death, show study results.
The U.S. Food and Drug Administration today exercised its new authority under the Food and Drug Administration Amendments Act of 2007 (FDAAA) to require manufacturers of "conventional" antipsychotic drugs to make safety-related changes to prescribing information, or labeling, to warn about an increased risk of death associated with the off-label use of these drugs to treat behavioral problems in older people with dementia.
› Verified 8 days ago
Sohrab Tanavoli, D.O Rheumatology Medicare: Medicare Enrolled Practice Location: 5901 E 7th St, Long Beach, CA 90822 Phone: 562-826-8000 | |
Ngoc-tram Gia Tran, D.O Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2888 Long Beach Blvd Ste 235, Long Beach, CA 90806 Phone: 562-803-2486 | |
Michael A Raya, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2600 Redondo Ave, Long Beach, CA 90806 Phone: 562-988-7000 | |
Meggan Chappell, Rheumatology Medicare: Medicare Enrolled Practice Location: 3833 Worsham Ave Ste 300, Long Beach, CA 90808 Phone: 562-595-5421 Fax: 562-426-2862 | |
Dr. Maurice A Bell, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4100 Long Beach Blvd, Suite 200, Long Beach, CA 90807 Phone: 562-981-2355 Fax: 562-981-2920 | |
Katya C Corado, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 1333 Chestnut Ave, Long Beach, CA 90813 Phone: 562-599-8601 Fax: 562-218-0853 | |
Dr. Diane L. Johnson, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 65 Pine Ave, #19, Long Beach, CA 90802 Phone: 714-402-4685 Fax: 562-856-0389 |